HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

BDNF and exercise enhance neuronal DNA repair by stimulating CREB-mediated production of apurinic/apyrimidinic endonuclease 1.

Abstract
Brain-derived neurotrophic factor (BDNF) promotes the survival and growth of neurons during brain development and mediates activity-dependent synaptic plasticity and associated learning and memory in the adult. BDNF levels are reduced in brain regions affected in Alzheimer's, Parkinson's, and Huntington's diseases, and elevation of BDNF levels can ameliorate neuronal dysfunction and degeneration in experimental models of these diseases. Because neurons accumulate oxidative lesions in their DNA during normal activity and in neurodegenerative disorders, we determined whether and how BDNF affects the ability of neurons to cope with oxidative DNA damage. We found that BDNF protects cerebral cortical neurons against oxidative DNA damage-induced death by a mechanism involving enhanced DNA repair. BDNF stimulates DNA repair by activating cyclic AMP response element-binding protein (CREB), which, in turn, induces the expression of apurinic/apyrimidinic endonuclease 1 (APE1), a key enzyme in the base excision DNA repair pathway. Suppression of either APE1 or TrkB by RNA interference abolishes the ability of BDNF to protect neurons against oxidized DNA damage-induced death. The ability of BDNF to activate CREB and upregulate APE1 expression is abolished by shRNA of TrkB as well as inhibitors of TrkB, PI3 kinase, and Akt kinase. Voluntary running wheel exercise significantly increases levels of BDNF, activates CREB, and upregulates APE1 in the cerebral cortex and hippocampus of mice, suggesting a novel mechanism whereby exercise may protect neurons from oxidative DNA damage. Our findings reveal a previously unknown ability of BDNF to enhance DNA repair by inducing the expression of the DNA repair enzyme APE1.
AuthorsJenq-Lin Yang, Yu-Ting Lin, Pei-Chin Chuang, Vilhelm A Bohr, Mark P Mattson
JournalNeuromolecular medicine (Neuromolecular Med) Vol. 16 Issue 1 Pg. 161-174 (Mar 2014) ISSN: 1559-1174 [Electronic] United States
PMID24114393 (Publication Type: Journal Article, Research Support, N.I.H., Intramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Brain-Derived Neurotrophic Factor
  • Creb1 protein, rat
  • Creb1 protein, mouse
  • Cyclic AMP Response Element-Binding Protein
  • Nerve Tissue Proteins
  • RNA, Small Interfering
  • Vitamin K 3
  • Receptor, trkB
  • Akt1 protein, mouse
  • Akt1 protein, rat
  • Proto-Oncogene Proteins c-akt
  • Apex1 protein, mouse
  • Apex1 protein, rat
  • DNA-(Apurinic or Apyrimidinic Site) Lyase
Topics
  • Animals
  • Brain-Derived Neurotrophic Factor (pharmacology, physiology)
  • Cerebral Cortex (cytology)
  • Cyclic AMP Response Element-Binding Protein (antagonists & inhibitors, physiology)
  • DNA Repair (drug effects, physiology)
  • DNA-(Apurinic or Apyrimidinic Site) Lyase (antagonists & inhibitors, biosynthesis, genetics)
  • Enzyme Induction (drug effects)
  • Hippocampus (cytology)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Nerve Tissue Proteins (antagonists & inhibitors, physiology)
  • Neurons (drug effects, metabolism)
  • Physical Conditioning, Animal
  • Proto-Oncogene Proteins c-akt (physiology)
  • RNA Interference
  • RNA, Small Interfering (pharmacology)
  • Random Allocation
  • Rats
  • Rats, Sprague-Dawley
  • Receptor, trkB (antagonists & inhibitors, physiology)
  • Vitamin K 3 (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: